Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotero Balance Lidocaine for Horizontal Forehead Lines
DRKS00031795Phase 4Completed
- Sponsor
- Merz
- Start
- May 2023
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Belotero Balance + lidocaine in Forehead lines, sponsored by Merz. Primary endpoints: Effectiveness of Belotero Balance Lidocaine for horizontal forehead lines and Safety of Belotero Balance Lidocaine for horizontal forehead lines. Started May 2023; status: completed.
02
Drugs
Belotero Balance + lidocaine
03
Conditions
Forehead lines
Beyond the preview
Go deeper on DRKS00031795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031795.